Wenfang Li
- Cancer Research top 10%
- Infectious Diseases top 10%
- Epidemiology top 10%
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications 4
- Physiology top 10%
-
- Cancer-related Molecular Pathways 6
-
- Tissue Engineering and Regenerative Medicine 5
-
- Pregnancy and preeclampsia studies 4
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 3
-
- Assisted Reproductive Technology and Twin Pregnancy 4
- Prenatal Screening and Diagnostics 3
Wenfang Li
65 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Cancer Research 167
- Infectious Diseases 180
- Epidemiology 320
- Biomaterials 104
- Physiology 32
Countries citing papers authored by Wenfang Li
This map shows the geographic impact of Wenfang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfang Li more than expected).
Fields of papers citing papers by Wenfang Li
This network shows the impact of papers produced by Wenfang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfang Li. The network helps show where Wenfang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenfang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 19 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 25 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 9 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 7 | |
| 14 | 2020 | 13 | |
| 15 | Growth of young HIV-infected and HIV-exposed children in western Kenya: A retrospective chart review | 2019 | 0 |
| 16 | 2019 | 22 | |
| 17 | 2019 | 25 | |
| 18 | 2017 | 3 | |
| 19 | 2013 | 1 | |
| 20 | 2013 | 12 |
About Wenfang Li
Wenfang Li is a scholar working on Obstetrics and Gynecology, Oncology and Biomaterials, having authored 76 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Tissue Engineering and Regenerative Medicine (5 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Pregnancy and preeclampsia studies (4 papers), Epigenetics and DNA Methylation (4 papers), Assisted Reproductive Technology and Twin Pregnancy (4 papers), Prenatal Screening and Diagnostics (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (167 citations), Infectious Diseases (180 citations) and Epidemiology (320 citations). Wenfang Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Richard W. Compans, Chinglai Yang, Yan Liu, Hongtao Chen, Guanmin Jiang, Hong Shan, Hao Wang, Peng Liang, Yuan Tan and Xiaojun Meng. Their work appears in journals such as International Journal of Molecular Sciences, BMC Pregnancy and Childbirth, Acta Biomaterialia, Journal of Clinical Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.